Discovery unveils promising anticancer drug targeting KRAS protein
byVirginia Commonwealth UniversityKRB-456 inhibits the growth in vivo of orthotopic mt KRAS tumors derived from pancreatic cancer patients. Tumor biopsies from pancreatic cancer patient G160 wer
Updated on: December 30,2023
Discovery unveils promising anticancer drug targeting KRAS protein
byVirginia Commonwealth UniversityKRB-456 inhibits the growth in vivo of orthotopic mt KRAS tumors derived from pancreatic cancer patients. Tumor biopsies from pancreatic cancer patient G160 wer
Updated on:December 30,2023
